nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Hepatic pain—Capecitabine—esophageal cancer	0.114	0.128	CcSEcCtD
Telbivudine—Floxuridine—TYMP—esophageal cancer	0.0542	0.496	CrCbGaD
Telbivudine—Hepatitis acute—Methotrexate—esophageal cancer	0.0489	0.0549	CcSEcCtD
Telbivudine—Trifluridine—TYMP—esophageal cancer	0.0431	0.394	CrCbGaD
Telbivudine—Abdominal pain lower—Capecitabine—esophageal cancer	0.03	0.0337	CcSEcCtD
Telbivudine—Amylase increased—Cisplatin—esophageal cancer	0.0272	0.0305	CcSEcCtD
Telbivudine—Rhinorrhoea—Cisplatin—esophageal cancer	0.016	0.0179	CcSEcCtD
Telbivudine—Tenderness—Cisplatin—esophageal cancer	0.0148	0.0166	CcSEcCtD
Telbivudine—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.0141	0.0159	CcSEcCtD
Telbivudine—Laryngeal pain—Capecitabine—esophageal cancer	0.014	0.0157	CcSEcCtD
Telbivudine—Hepatomegaly—Capecitabine—esophageal cancer	0.0135	0.0151	CcSEcCtD
Telbivudine—Pain—Carboplatin—esophageal cancer	0.0135	0.0151	CcSEcCtD
Telbivudine—Body temperature increased—Carboplatin—esophageal cancer	0.0124	0.014	CcSEcCtD
Telbivudine—Rhinorrhoea—Capecitabine—esophageal cancer	0.0118	0.0132	CcSEcCtD
Telbivudine—Chest discomfort—Capecitabine—esophageal cancer	0.0108	0.0121	CcSEcCtD
Telbivudine—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.0106	0.0119	CcSEcCtD
Telbivudine—Neck pain—Capecitabine—esophageal cancer	0.00965	0.0108	CcSEcCtD
Telbivudine—Influenza like illness—Capecitabine—esophageal cancer	0.00926	0.0104	CcSEcCtD
Telbivudine—Zidovudine—CYP2A6—esophageal cancer	0.00874	0.08	CrCbGaD
Telbivudine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00845	0.00949	CcSEcCtD
Telbivudine—Cramp muscle—Cisplatin—esophageal cancer	0.00845	0.00949	CcSEcCtD
Telbivudine—Nasopharyngitis—Cisplatin—esophageal cancer	0.00839	0.00942	CcSEcCtD
Telbivudine—Sepsis—Capecitabine—esophageal cancer	0.00827	0.00929	CcSEcCtD
Telbivudine—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00791	0.00888	CcSEcCtD
Telbivudine—Abdominal discomfort—Cisplatin—esophageal cancer	0.00778	0.00873	CcSEcCtD
Telbivudine—Renal impairment—Capecitabine—esophageal cancer	0.00727	0.00816	CcSEcCtD
Telbivudine—Renal failure—Cisplatin—esophageal cancer	0.00711	0.00798	CcSEcCtD
Telbivudine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00709	0.00796	CcSEcCtD
Telbivudine—Pain in extremity—Capecitabine—esophageal cancer	0.00692	0.00777	CcSEcCtD
Telbivudine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00684	0.00768	CcSEcCtD
Telbivudine—Migraine—Capecitabine—esophageal cancer	0.00681	0.00765	CcSEcCtD
Telbivudine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00638	0.00716	CcSEcCtD
Telbivudine—Abdominal pain upper—Capecitabine—esophageal cancer	0.00632	0.0071	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00623	0.007	CcSEcCtD
Telbivudine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00619	0.00695	CcSEcCtD
Telbivudine—Sepsis—Methotrexate—esophageal cancer	0.00616	0.00691	CcSEcCtD
Telbivudine—Gastritis—Capecitabine—esophageal cancer	0.00612	0.00688	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.0061	0.00685	CcSEcCtD
Telbivudine—Muscular weakness—Capecitabine—esophageal cancer	0.0061	0.00685	CcSEcCtD
Telbivudine—Abdominal distension—Capecitabine—esophageal cancer	0.00602	0.00676	CcSEcCtD
Telbivudine—Influenza—Capecitabine—esophageal cancer	0.00598	0.00671	CcSEcCtD
Telbivudine—Mediastinal disorder—Cisplatin—esophageal cancer	0.00585	0.00657	CcSEcCtD
Telbivudine—Abdominal discomfort—Capecitabine—esophageal cancer	0.00573	0.00644	CcSEcCtD
Telbivudine—Malnutrition—Cisplatin—esophageal cancer	0.00565	0.00635	CcSEcCtD
Telbivudine—Neutropenia—Capecitabine—esophageal cancer	0.00559	0.00628	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00556	0.00624	CcSEcCtD
Telbivudine—Muscle spasms—Cisplatin—esophageal cancer	0.00543	0.0061	CcSEcCtD
Telbivudine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00524	0.00589	CcSEcCtD
Telbivudine—Renal failure—Capecitabine—esophageal cancer	0.00524	0.00588	CcSEcCtD
Telbivudine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00523	0.00587	CcSEcCtD
Telbivudine—Malaise—Cisplatin—esophageal cancer	0.0051	0.00572	CcSEcCtD
Telbivudine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00504	0.00566	CcSEcCtD
Telbivudine—Myalgia—Cisplatin—esophageal cancer	0.00481	0.0054	CcSEcCtD
Telbivudine—Hepatitis—Capecitabine—esophageal cancer	0.00479	0.00537	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00478	0.00537	CcSEcCtD
Telbivudine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00476	0.00535	CcSEcCtD
Telbivudine—Discomfort—Cisplatin—esophageal cancer	0.00475	0.00534	CcSEcCtD
Telbivudine—Pharyngitis—Capecitabine—esophageal cancer	0.00475	0.00533	CcSEcCtD
Telbivudine—Connective tissue disorder—Capecitabine—esophageal cancer	0.0047	0.00528	CcSEcCtD
Telbivudine—Nervous system disorder—Cisplatin—esophageal cancer	0.00452	0.00508	CcSEcCtD
Telbivudine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00452	0.00507	CcSEcCtD
Telbivudine—Skin disorder—Cisplatin—esophageal cancer	0.00448	0.00503	CcSEcCtD
Telbivudine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00431	0.00484	CcSEcCtD
Telbivudine—Abdominal discomfort—Methotrexate—esophageal cancer	0.00427	0.00479	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.0042	0.00472	CcSEcCtD
Telbivudine—Malnutrition—Capecitabine—esophageal cancer	0.00417	0.00468	CcSEcCtD
Telbivudine—Neutropenia—Methotrexate—esophageal cancer	0.00416	0.00467	CcSEcCtD
Telbivudine—Paraesthesia—Cisplatin—esophageal cancer	0.00414	0.00465	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00414	0.00465	CcSEcCtD
Telbivudine—Dysgeusia—Capecitabine—esophageal cancer	0.00408	0.00458	CcSEcCtD
Telbivudine—Back pain—Capecitabine—esophageal cancer	0.00403	0.00453	CcSEcCtD
Telbivudine—Muscle spasms—Capecitabine—esophageal cancer	0.00401	0.0045	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00398	0.00447	CcSEcCtD
Telbivudine—Pain—Cisplatin—esophageal cancer	0.00395	0.00443	CcSEcCtD
Telbivudine—Renal failure—Methotrexate—esophageal cancer	0.0039	0.00438	CcSEcCtD
Telbivudine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00387	0.00434	CcSEcCtD
Telbivudine—Feeling abnormal—Cisplatin—esophageal cancer	0.0038	0.00427	CcSEcCtD
Telbivudine—Malaise—Capecitabine—esophageal cancer	0.00376	0.00422	CcSEcCtD
Telbivudine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00375	0.00421	CcSEcCtD
Telbivudine—Body temperature increased—Cisplatin—esophageal cancer	0.00365	0.00409	CcSEcCtD
Telbivudine—Cough—Capecitabine—esophageal cancer	0.00364	0.00408	CcSEcCtD
Telbivudine—Hepatitis—Methotrexate—esophageal cancer	0.00356	0.004	CcSEcCtD
Telbivudine—Myalgia—Capecitabine—esophageal cancer	0.00355	0.00398	CcSEcCtD
Telbivudine—Arthralgia—Capecitabine—esophageal cancer	0.00355	0.00398	CcSEcCtD
Telbivudine—Chest pain—Capecitabine—esophageal cancer	0.00355	0.00398	CcSEcCtD
Telbivudine—Pharyngitis—Methotrexate—esophageal cancer	0.00354	0.00397	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00352	0.00396	CcSEcCtD
Telbivudine—Discomfort—Capecitabine—esophageal cancer	0.00351	0.00394	CcSEcCtD
Telbivudine—Nervous system disorder—Capecitabine—esophageal cancer	0.00334	0.00374	CcSEcCtD
Telbivudine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00333	0.00374	CcSEcCtD
Telbivudine—Asthenia—Cisplatin—esophageal cancer	0.00331	0.00372	CcSEcCtD
Telbivudine—Skin disorder—Capecitabine—esophageal cancer	0.0033	0.00371	CcSEcCtD
Telbivudine—Zidovudine—ABCB1—esophageal cancer	0.00325	0.0298	CrCbGaD
Telbivudine—Mediastinal disorder—Methotrexate—esophageal cancer	0.00321	0.00361	CcSEcCtD
Telbivudine—Diarrhoea—Cisplatin—esophageal cancer	0.00316	0.00354	CcSEcCtD
Telbivudine—Malnutrition—Methotrexate—esophageal cancer	0.0031	0.00348	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0031	0.00348	CcSEcCtD
Telbivudine—Insomnia—Capecitabine—esophageal cancer	0.00308	0.00345	CcSEcCtD
Telbivudine—Paraesthesia—Capecitabine—esophageal cancer	0.00305	0.00343	CcSEcCtD
Telbivudine—Dysgeusia—Methotrexate—esophageal cancer	0.00304	0.00341	CcSEcCtD
Telbivudine—Back pain—Methotrexate—esophageal cancer	0.003	0.00337	CcSEcCtD
Telbivudine—Dyspepsia—Capecitabine—esophageal cancer	0.00299	0.00336	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00294	0.0033	CcSEcCtD
Telbivudine—Vomiting—Cisplatin—esophageal cancer	0.00293	0.00329	CcSEcCtD
Telbivudine—Fatigue—Capecitabine—esophageal cancer	0.00293	0.00329	CcSEcCtD
Telbivudine—Rash—Cisplatin—esophageal cancer	0.00291	0.00327	CcSEcCtD
Telbivudine—Pain—Capecitabine—esophageal cancer	0.00291	0.00327	CcSEcCtD
Telbivudine—Dermatitis—Cisplatin—esophageal cancer	0.00291	0.00326	CcSEcCtD
Telbivudine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00288	0.00323	CcSEcCtD
Telbivudine—Feeling abnormal—Capecitabine—esophageal cancer	0.0028	0.00315	CcSEcCtD
Telbivudine—Malaise—Methotrexate—esophageal cancer	0.0028	0.00314	CcSEcCtD
Telbivudine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00278	0.00312	CcSEcCtD
Telbivudine—Nausea—Cisplatin—esophageal cancer	0.00274	0.00308	CcSEcCtD
Telbivudine—Cough—Methotrexate—esophageal cancer	0.00271	0.00304	CcSEcCtD
Telbivudine—Abdominal pain—Capecitabine—esophageal cancer	0.00269	0.00302	CcSEcCtD
Telbivudine—Body temperature increased—Capecitabine—esophageal cancer	0.00269	0.00302	CcSEcCtD
Telbivudine—Arthralgia—Methotrexate—esophageal cancer	0.00264	0.00297	CcSEcCtD
Telbivudine—Myalgia—Methotrexate—esophageal cancer	0.00264	0.00297	CcSEcCtD
Telbivudine—Chest pain—Methotrexate—esophageal cancer	0.00264	0.00297	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00262	0.00294	CcSEcCtD
Telbivudine—Discomfort—Methotrexate—esophageal cancer	0.00261	0.00293	CcSEcCtD
Telbivudine—Nervous system disorder—Methotrexate—esophageal cancer	0.00248	0.00279	CcSEcCtD
Telbivudine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00248	0.00278	CcSEcCtD
Telbivudine—Skin disorder—Methotrexate—esophageal cancer	0.00246	0.00276	CcSEcCtD
Telbivudine—Asthenia—Capecitabine—esophageal cancer	0.00244	0.00274	CcSEcCtD
Telbivudine—Pruritus—Capecitabine—esophageal cancer	0.00241	0.0027	CcSEcCtD
Telbivudine—Diarrhoea—Capecitabine—esophageal cancer	0.00233	0.00261	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00231	0.00259	CcSEcCtD
Telbivudine—Insomnia—Methotrexate—esophageal cancer	0.00229	0.00257	CcSEcCtD
Telbivudine—Paraesthesia—Methotrexate—esophageal cancer	0.00227	0.00255	CcSEcCtD
Telbivudine—Dizziness—Capecitabine—esophageal cancer	0.00225	0.00252	CcSEcCtD
Telbivudine—Dyspepsia—Methotrexate—esophageal cancer	0.00223	0.0025	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00219	0.00245	CcSEcCtD
Telbivudine—Fatigue—Methotrexate—esophageal cancer	0.00218	0.00245	CcSEcCtD
Telbivudine—Pain—Methotrexate—esophageal cancer	0.00216	0.00243	CcSEcCtD
Telbivudine—Vomiting—Capecitabine—esophageal cancer	0.00216	0.00243	CcSEcCtD
Telbivudine—Rash—Capecitabine—esophageal cancer	0.00214	0.00241	CcSEcCtD
Telbivudine—Dermatitis—Capecitabine—esophageal cancer	0.00214	0.00241	CcSEcCtD
Telbivudine—Headache—Capecitabine—esophageal cancer	0.00213	0.00239	CcSEcCtD
Telbivudine—Feeling abnormal—Methotrexate—esophageal cancer	0.00209	0.00234	CcSEcCtD
Telbivudine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00207	0.00232	CcSEcCtD
Telbivudine—Nausea—Capecitabine—esophageal cancer	0.00202	0.00227	CcSEcCtD
Telbivudine—Abdominal pain—Methotrexate—esophageal cancer	0.002	0.00225	CcSEcCtD
Telbivudine—Body temperature increased—Methotrexate—esophageal cancer	0.002	0.00225	CcSEcCtD
Telbivudine—Asthenia—Methotrexate—esophageal cancer	0.00182	0.00204	CcSEcCtD
Telbivudine—Pruritus—Methotrexate—esophageal cancer	0.00179	0.00201	CcSEcCtD
Telbivudine—Diarrhoea—Methotrexate—esophageal cancer	0.00173	0.00194	CcSEcCtD
Telbivudine—Dizziness—Methotrexate—esophageal cancer	0.00167	0.00188	CcSEcCtD
Telbivudine—Vomiting—Methotrexate—esophageal cancer	0.00161	0.00181	CcSEcCtD
Telbivudine—Rash—Methotrexate—esophageal cancer	0.0016	0.00179	CcSEcCtD
Telbivudine—Dermatitis—Methotrexate—esophageal cancer	0.00159	0.00179	CcSEcCtD
Telbivudine—Headache—Methotrexate—esophageal cancer	0.00159	0.00178	CcSEcCtD
Telbivudine—Nausea—Methotrexate—esophageal cancer	0.0015	0.00169	CcSEcCtD
